Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in the Treatment of Schizophrenia
IRCT138902241556N13Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of memantine in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Jun 2010; status: completed.
02
Drugs
memantine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT138902241556N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138902241556N13.